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Cardiovascular disease (CVD) is the leading non-communicable 
disease (NCD) globally, contributing to 17 million deaths annually.[1] 
According to the World Health Organization (WHO), more than 1.1 
million deaths in the African region in 2005 were caused by CVDs 
and over half of these were caused by ischaemic heart disease and 
stroke.[2] Projections suggest that this figure will almost double by 
2030 and that ischaemic heart disease and stroke will overtake HIV as 
the leading cause of death in sub-Saharan Africa by 2030.[3]
The need to investigate and address the underlying causes of 
CVD in Africa has become urgent. Establishing observational 
cohort studies to study the biological, social, cultural and economic 
determinants of NCDs in low- and middle-income countries has 
been identified by the WHO as an important research priority.[1] 
Yet data on NCDs in Africa are sparse,[4] and there is currently great 
disparity in the number of adults enrolled in long-term cohorts in 
Africa compared with developed countries.[5] This is problematic, 
as geographical, cultural, social and genetic differences between 
populations may limit the applicability of scientific findings from 
the North to the African continent. Adult health has been studied 
with success in other countries using professional cohorts such as 
the Nurses’ Health Study, a teacher cohort in the EsMaestra study in 
Mexico[6] and the California Teachers Study.[7]
Objective
The Partnership for Cohort Research and Training (PaCT) has 
been initiated to study NCDs among a cohort of people drawn 
from various settings in four African countries (South Africa (SA), 
Uganda, Tanzania and Nigeria) with the intention of following 
them over several years. To assess the feasibility of this approach, 
pilot studies were conducted at each of the sites involved. The SA 
pilot study, the findings from which are reported in this article, 
was conducted among teachers and aimed to: (i) determine the 
prevalence and distribution of CVD risk factors and self-reported 
heart disease and stroke; (ii) determine the percentage of participants 
in three categories of 10-year predicted risk of a fatal or non-fatal 
cardiovascular event; and (iii) evaluate the feasibility of conducting a 
cohort study of NCDs among teachers.
Methods
Design and setting
The methods used in PaCT pilot studies are described in an over view 
article relating to the feasibility of a cohort study in sub-Saharan 
Africa.[8] A baseline survey and 6-month longitudinal follow-up 
were conducted between January 2011 and May 2012 in the SA pilot. 
We aimed to recruit 1 000 teachers aged 18 years and older from 
public schools in the urban area of the Metro South Education District 
(MSED) in Cape Town, SA. The MSED contains 4 166 teachers 
employed at 189 schools, representing different socioeconomic levels. 
To improve recruitment, we selected schools where ≥20 teachers 
were employed, resulting in a total of 111 schools with approxi-
mately 3 166 teachers. We first requested written permission from 
the principals and then sent questionnaire-consent packages for 
distribution at the schools. Participants received feedback about 
their blood pressure and laboratory results by personalised SMS (text 
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message) or email and were advised to see 
their regular doctor for readings outside the 
normal range. Communication with schools 
was primarily through telephone and email, 
to assess whether these methods could be 
used effectively in a countrywide cohort.
Data collection
Willing teachers enrolled by completing the 
consent forms and a 1-hour-long baseline 
questionnaire, and returned these in prepaid 
envelopes to the study co-ordination centre. 
Trained nurses visited schools at prearranged 
times to collect physical measurements 
(blood pressure, pulse rate, height, weight 
and waist circumference) and non-fasting 
biological samples (blood and urine) from 
participants. Details about data collection 
and measurements are summarised in 
Appendix 1. Willing participants received 
a follow-up questionnaire by email or post, 
according to their preference.
A personal history of heart disease or stroke 
was self-reported; a positive family history 
referred to first-degree relatives with coronary 
heart disease (CHD) or stroke. Being a current 
smoker was defined as self-reported use of 
tobacco products at the time of assessment. 
Hypertension was defined as having a 
systolic blood pressure ≥140 mmHg or a 
diastolic blood pressure ≥90 mmHg or being 
on antihypertensive treatment. Dia betes was 
defined as having a non-fasting blood glucose 
level ≥11.1 mmol/L or being on hypoglycaemic 
treatment. A desira ble total cholesterol (TC) 
level was defined as <5.18 mmol/L, borderline 
high TC as 5.18 - 6.21 mmol/L, high TC 
as 6.22 - 7.99 mmol/L and extremely high 
TC as ≥8 mmol/L.[9] Chronic kidney disease 
(CKD) was defined as having proteinuria 
≥0.30 mg/mg or a glomerular filtration rate 
(GFR) <60 mL/min/1.73 m2, calculated 
using the re-expressed Modification of Diet 
in Renal Disease (MDRD) study equation, 
or self-reported structural abnormalities of 
the kidneys. A body mass index (BMI) of 
25.0 - 29.9 kg/m2 was classified as being 
overweight and a BMI of ≥30 kg/m2 as being 
obese. Abdominal obesity was defined using 
the National Cholesterol Education Program 
Third Adult Treatment Panel (NCEP-ATP 
III) recommendations (waist circumference 
≥102 cm for males and ≥88 cm for females) 
and the International Diabetes Federation 
(IDF) recommendations (waist circumference 
≥94 cm for males and ≥80 cm for females).
Ethical considerations
Ethical approval for the South African 
PaCT pilot study was obtained from the 
Health Research Ethics Committee of the 
Faculty of Medicine and Health Sciences at 
Stellenbosch University (ref. no. N10/05/172) 
and the Harvard School of Public Health 
(HSPH) Institutional Review Board (ref. no. 
19431-101). The Western Cape Education 
Department approved the study (ref. no. 
20100426-0012) and the relevant teacher 
trade unions were informed about the study 
through a letter sent to their provincial offices.
Analysis
Cardiovascular risk prediction
Participants were categorised as at high risk 
(≥20.0%), intermediate risk (10.0 - 19.9%) or 
low risk (0 - 9.9%) for heart attack or stroke 
in the following 10 years, using the WHO 
and International Society of Hypertension 
(WHO/ISH) cardiovascular risk prediction 
charts for the WHO epidemiological sub-
region AFR E (SA).[10] Categorisation is based 
on five risk factors: age, current smoking 
status, systolic blood pressure, TC and 
presence or absence of diabetes mellitus. 
In addition, participants with established 
CVD (self-reported CHD or stroke), very 
high levels of individual risk factors (TC 
≥8 mmol/L, or TC/high-density lipoprotein 
cholesterol (TC/HDL-C) ratio >8, or a blood 
pressure >160/100 mmHg) or CKD were 
categorised as having high cardiovascular 
risk. In a post-hoc analysis, the impact of 
BMI on CVD risk was assessed using the 
non-laboratory-based Framingham 10-year 
risk calculator.[11]
Statistical analysis
Statistical analysis of the data was performed 
using STATA IC 10 statistical software 
(StataCorp, USA). Continuous variables 
were summarised as means (standard 
deviation (SD)) for normally distributed 
data and medians (interquartile range 
(IQR)) for asymmetrical data. Categorical 
variables were summarised as frequencies 
and percentages. Independent-sample t-tests 
were used to compare means of normally 
distributed continuous variables between 
groups, while χ2 tests were used to compare 
proportions. Where cardiovascular risk 
factors were compared between men and 
women, p-values were derived from Wald 
χ2 tests using multivariate binary logistic 
regression, adjusting for age and clustering 
by school. Predicted cardiovascular risk 
estimates are reported as proportions and 
95% confidence intervals (CIs) and were 
adjusted for clustering by school.
Results
Baseline study sample and 
characteristics
The baseline sample consisted of 489 parti-
cipants, of whom 70.3% were females. 
The mean age of participants at baseline 
was 46.3  years (SD 8.5). Cardiovascular 
risk could not be determined for 12 male 
and 23 female participants, including 3 
of unknown age, 19 who had no blood 
pressure readings and 13 with unknown 
diabetic status. Therefore 454 participants 
were included in the analysis.
Baseline characteristics summarised  by 
gender are shown in Table  1. With the 
excep tion of age (p=0.733) and blood glu-
cose (p=0.659), significant differences were 
Table 1. Baseline characteristics stratified by gender
Characteristic
Male
(N=133)
Female
(N=321) p-value
Age (yr), mean (SD) 46.8 (9.1) 46.5 (8.0) 0.733
Current smoking (n, %) 31 (24.4) 45 (15.2) 0.042
Systolic blood pressure (mmHg), mean (SD)  140.2 (17.9) 131.8 (18.3) <0.001
Diastolic blood pressure (mmHg), mean (SD)  81.6 (10.6) 78.3 (10.8) 0.004
Blood glucose (mmol/L), median (IQR) 5.2 (4.7 - 5.8) 5.2 (4.7 - 5.8) 0.659
TC (mmol/L), mean (SD)  5.5 (0.99) 5.3 (1.1) 0.031
HDL-C (mmol/L), mean (SD) 1.2 (0.3) 1.5 (0.4) <0.001
Serum creatinine (μmol/L), median (IQR) 90 (80 - 99) 66 (59 - 74) <0.001
Urinary protein creatinine ratio (mg/mg), 
median (IQR)  
0.06 (0.05 - 0.07) 0.08 (0.06 - 0.11) <0.001
GFR* (mL/min/1.73 m2), mean (SD) 80.8 (15.1) 85.0 (17.1) 0.011
Height (m), mean (SD)  1.73 (0.08) 1.58 (0.06) <0.001
Weight (kg), mean (SD)  87.8 (17.7) 81.2 (18.4) <0.001
BMI (kg/m2), mean (SD)  29.1 (4.8) 32.4 (7.0) <0.001
Waist circumference (cm), mean (SD)  97.6 (12.7) 94.6 (13.8) 0.029
*GFR based on re-expressed MDRD equation.
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observed between males and females. More 
males indicated that they were current 
smokers (p=0.042), with the highest propor-
tion of smokers being in the age category 
50 - 59.9 years for both genders. The aver-
age systolic and diastolic blood pressure for 
males was higher than for females (p<0.001 
and p=0.004, respectively). The mean BMI 
for males was in the overweight category 
and for females was in the obese category 
(p<0.001).
Prevalence of CVD risk factors
Cardiovascular risk factors are shown 
for the total population, and stratified by 
gender (Table 2). Of the total population, 
48.5% (220/454) had hypertension. Less 
than half of these participants (106/220, 
48.2%) reported being on antihypertensive 
treatment and only half of those who were on 
medication had readings within the normal 
range. Of the participants, 10.1% (46/454) 
had diabetes and a further 3.3% (15/454) 
were at an increased risk of diabetes, based 
on having a random plasma glucose level 
between 7.8 and 11.0 mmol/L. Less than half 
(44.6%) of the participants had random TC 
levels within the normal range. Males had 
a higher prevalence of smoking (p=0.042), 
hypertension based on blood pressure 
readings (p=0.001), and TC/HDL-C ratio >8 
(p=0.031), while more females were obese 
(p=0.007) and abdominally obese (p<0.001).
Obesity and family history
Only 15.2% of participants had a BMI within 
the normal range, while 31.1% of participants 
had a BMI in the overweight range and 
a further 53.6% had a BMI in the obese 
range. According to the NCEP-ATP III and 
IDF recommendations, 61.2% and 78.4% of 
participants, respectively, were abdominally 
obese. Of the participants, 41.6% reported 
a family history of CHD or stroke among 
first-degree relatives, with similar rates for 
males and females.
Calculated CVD risk
The risk of suffering a CVD event over the 
following 10 years, according to the WHO/ISH 
risk prediction charts and the Framing ham 
risk calculator using BMI, is shown in Table 3. 
Based on the WHO/ISH risk prediction charts, 
79.7% (95% CI  74.9 - 84.6%) of participants 
were at low cardiovascular risk, 1.6% (95% 
CI 0.1 - 3.0%) were at intermediate risk and 
18.7% (95% CI 14.2 - 23.1%) were at high risk. 
Of these, only 3 participants were categorised 
at high risk based on the charts alone. A 
further 82 participants were categorised at high 
risk either because of established CVD (self-
reported CHD or stroke), very high levels of 
individual risk factors (TC ≥8 mmol/L, or TC/
HDL-C ratio >8, or blood pressure >160/100 
mmHg) or CKD.
The Framingham risk calculator identi-
fied more participants at intermediate risk 
(21.4%, 95% CI 18.0 - 24.9%) probably 
because of the important role of overweight 
and obesity. However, it categorised fewer 
participants at high risk (13.9%, 95% CI 9.9 - 
18.0%) because it does not take CKD or 
extreme cholesterol and blood pressure 
levels into account.
Table 2. Distribution of cardiovascular risk factors by gender
Cardiovascular risk factor
Total
(N=454)
n (%)
Male
(N=133)
n (%)
Female
(N=321)
n (%) p-value*
Current smoker (N=423) 76 (18.0) 31 (24.4) 45 (15.2) 0.042
Hypertension† 220 (48.5) 72 (54.1) 148 (46.1) 0.121
Blood pressure ≥140/90 mmHg 166 (36.6) 63 (47.4) 103 (32.1) 0.001
Blood pressure ≥160/100 mmHg 42 (9.3) 15 (11.3) 27 (8.4) 0.379
Diabetes‡ 46 (10.1) 17 (12.8) 29 (9.0) 0.167
Glucose 7.8 - 11.0 mmol/L 15 (3.3) 2 (1.5) 13 (4.1) 0.148
TC§ (N=448)
Borderline high 156 (34.8) 51 (38.4) 105 (33.3) 0.340
High 87 (19.4) 31 (23.3) 56 (17.8) 0.281
Extremely high 5 (1.1) 1 (0.8) 4 (1.3) 0.484
TC/HDL-C ratio >8 4 (0.9) 3 (2.3) 1 (0.3) 0.031
Personal history of CHD¶/stroke 
(N=445)
19 (4.3) 9 (6.9) 10 (3.2) 0.054
Family history of CHD/stroke|| 
(N=445)
185 (41.6) 53 (40.5) 132 (42.0) 0.782
CKD** 47 (10.4) 12 (9.0) 35 (10.9) 0.559
Overweight†† 141 (31.1) 56 (42.4) 85 (26.5) 0.811
Obese†† 243 (53.6) 49 (37.1) 194 (60.4) 0.007
Abdominal obesity (NCEP-ATPIII)‡‡ 277 (61.2) 54 (40.6) 223 (69.7) <0.001
Abdominal obesity (IDF)§§ 355 (78.4) 81 (60.9) 274 (85.6) <0.001
*p-value derived from Wald χ2 test using multivariate binary logistic regression adjusting for age and clustering by school.
†Hypertension: systolic blood pressure ≥140 mmHg, or diastolic blood pressure ≥90 mmHg, or self-reported hypertension on 
antihypertensive treatment.
‡Diabetes: fasting (>8 hours) plasma glucose concentration ≥7.0 mmol/L (126 mg/dL), or random (~2 hours after a main meal) 
plasma glucose concentration >11.0 mmol/L (200 mg/L), or self-reported diabetes on insulin or oral hypoglycaemic drugs.
§TC: desirable <5.18 mmol/L, borderline high 5.18 - 6.21 mmol/L, high 6.22 - 7.99 mmol/L, extremely high ≥8 mmol/L.
¶Personal history of CHD: personal history of CHD, including angina and coronary artery disease.
||Family: first-degree relatives with CHD or stroke.
**CKD: defined as proteinuria ≥0.30 mg/mg or GFR <60 mL/min/1.73 m2 using the re-expressed MDRD equation, or self-
reported structural abnormalities of the kidneys.
††Overweight: BMI ≥25.0 - 29.9 kg/m2, obese: BMI ≥30 kg/m2.
‡‡NCEP-ATP-III definition for abdominal obesity: male ≥102 cm, female ≥88 cm.
§§IDF definition for abdominal obesity: male ≥94 cm, female ≥80 cm.
Table 3. The 10-year predicted CVD risk using the WHO/ISH charts and the 
Framingham risk calculator
10-year predicted CVD risk
WHO/ISH risk chart*
(N=454)
n (cluster-adjusted %, 
95% CI)
Framingham risk calculator using 
BMI†
(N=454)
n (cluster-adjusted %, 95% CI)
Low (0 - 9.9%) 362 (79.7, 74.9 - 84.6) 293 (64.6, 59.7 - 69.4)
Intermediate (10 - 19.9%) 7 (1.6, 0.1 - 3.0) 97 (21.4, 18.0 - 24.9)
High (≥20%) 85 (18.7, 14.2 - 23.1) 63 (13.9, 9.9 - 18.0)
*The WHO/ISH charts incorporate gender, age, smoking status, systolic blood pressure, TC and diabetes. In addition, 
established CVD (CHD/stroke), CKD and extremely high levels of cholesterol and blood pressure were categorised as high risk.
†The Framingham risk calculator incorporates gender, age, smoking status, systolic blood pressure, treatment for hypertension 
and diabetes, and BMI.
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Cohort feasibility
Results from recruitment at baseline and 
retention after 6 months are summarised 
in Fig. 1. Following three rounds of invi-
tation, 53.2% (59/111) principals agreed 
to  the parti cipation of their school, 32.4% 
(36/111) declined either without reason 
or reported a lack of time or interest from 
the teachers, and 14.4% (16/111) did not 
reply following several reminders. Based 
on the number of teachers employed, 1 779 
questionnaire-consent packages were deliv-
ered to participating schools. A total of 489 
teachers enrolled in the study and 478 of 
these completed a baseline questionnaire. 
Participation was better at the schools 
where the principals themselves enrolled, 
with 42.2% (444/1 053) document packages 
returned from their schools compared with 
only 6.2% (45/726) from schools where 
the principal chose not to enrol. We also 
found that more primary school principals 
agreed to participate (39/67 schools, 58.2%) 
compared with secondary school principals 
(20/44 schools, 45.5%), and more primary 
school teachers enrolled (328/1121, 29.2%) 
compared with secondary school teachers 
(161/658, 24.5%).
Cardiovascular risk could not be deter-
mined for 35 participants in our analyses 
because of missing data. Questions relating 
to infectious conditions and mental 
health had more missing responses, with 
41 and 149 participants choosing not to 
answer questions relating to TB and HIV, 
respectively, and 90 participants with 
missing mental health data.[12] This may be 
explained by the sensitive nature of these 
questions. Across all sites, a strong number 
of participants indicated a willingness to 
provide biological samples and 93% of SA 
participants provided blood samples.
At the 6-month follow-up, assessment 
questionnaires were sent to 425 participants 
who had indicated at baseline that they were 
willing to participate in the follow-up, and 
52.0% (221/425) of these were returned. 
Posted questionnaires were returned by 
75.0%, compared with 25.0% who responded 
through email.
Discussion
CVD risk factors and calculated 
CVD risk
Teachers in the MSED in Cape Town 
represent a group at high risk of chronic 
NCDs, in particular CVD. In this study, 
18.7% of 454 participants were at a high 
risk of developing a heart attack or stroke 
during the next 10 years, requiring intensive 
lifestyle interventions and appropriate 
drug therapy. The Framingham risk score 
that incorporates BMI identified more 
participants at intermediate risk but fewer 
participants at high risk compared with 
the WHO/ISH charts.[10,11] It is therefore 
important to incorporate BMI into risk 
calculators for SA as well as taking CKD 
and extreme cholesterol and blood pressure 
levels into account.
With the exception of diabetes, the SA 
PaCT pilot study population had a higher 
prevalence for each individual risk factor 
than the crude adjusted estimates for South 
Africans reported in the WHO Global Status 
Report on NCDs for 2008[13] (Table 4). The 
prevalence of hypertension in this pilot 
was lower (48.5%) than that reported in 
the PURE NCD risk factor study for SA 
participants (57.1%).[14] Rates of overweight, 
obesity and central obesity were high in our 
study. In the NHANES-1 study, 43.0% of 
males and 62.4% of females in Western Cape 
Province had a BMI >25 kg/m2,[15] compared 
with 79.3% and 86.9%, respectively, found 
in our study. This could be explained by the 
urban location of our pilot, with teachers 
having better access to food and less free 
time to exercise.
Cohort feasibility
Teachers represent an ideal group for 
studying the aetiology of NCDs through 
longitudinal studies because of their large 
numbers, gender and ethnic diversity, 
range of exposures and the ease with which 
they can be located. However, recruitment 
and retention among teachers has unique 
challenges, such as long interruptions in 
recruitment because of school holidays. The 
low response from principals (53.2%) and 
teachers at baseline (489/1 779 documents 
Baseline: 111 school principals invited to participate
36 declined
16 no response
59 principals gave written permission to approach their teachers
1 779 document packs delivered to participating schools
1 243 returned
43 responded but declined
4 non-teachers excluded
489 teachers enrolled in the study
Willingness to participate in follow-up
indicated at baseline:
405 willing
53 not willing
20 not indicated
11 no baseline questionnaire
Follow-up after 6 months: 221/425 participants
Fig. 1. Recruitment at baseline and retention after 6 months.
Table 4. Prevalence of risk factors for CVD in the SA PaCT pilot study compared with 
crude adjusted 2008 estimates reported for SA in the WHO Global Status Report on 
NCDs[13]
CVD risk factor
SA PaCT pilot study,
% (95% CI)
Global Status Report on NCDs,
% (95% CI) 
Smoking 17.9 (14.3 - 21.6) 14.0 (11.7 - 16.3)
Raised TC 55.4 (50.7 - 59.9) 34.0 (20.7 - 49.2)
Overweight and obesity 84.8 (81.4 - 88.1) 65.4 (61.8 - 68.5)
Hypertension 48.5 (43.8 - 53.1) 42.2 (38.4 - 46.2)
Diabetes 10.1 (7.3 - 12.9) 10.6 (7.0 - 14.8)
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returned), as well as low retention after 6-month follow-up (52.0%) 
indicates that our methods to recruit and retain teachers into a large 
cohort study need improvement. Further pilot studies are necessary 
to test the best methods of recruiting large numbers of participants, 
keeping in mind the need for recruitment methods to be sufficiently 
simple to be scalable.
The majority of participants (91.0%) were from schools where the 
principals themselves enrolled, reflecting the importance of gaining 
principals’ support and enrolling them first. Alternatively, efficient 
methods of enrolling teachers directly, as done in the esMaestra 
study in Mexico[6] and the California Teachers Study,[7] could be 
tried. Lower participation rates at secondary schools (24.5%) than 
primary schools (29.2%) may be explained by secondary school 
teachers having less spare time. Participation could be improved 
by raising awareness about chronic NCDs and the importance of 
research before recruitment starts, meeting with the principals 
directly, simplifying and shortening the questionnaires and focusing 
on primary school teachers. To prevent loss of documents through 
the postal system and to improve completeness of information, data 
should be collected through an interviewer or obtained online.
The PaCT pilot studies conducted in Uganda and Nigeria reached 
their target sample size at enrolment and showed the highest retention 
rates at 6-month follow-up, ranging between 85.0% and 96.0%. 
In Nigeria, nurses were enrolled and in Uganda participants were 
enrolled from rural and peri-urban communities and data collected 
through face-to-face interview, whereas in SA and Tanzania teachers 
were enrolled and data collected by self-administered questionnaires 
returned by post.[8] Better response rates in Nigeria and Uganda 
indicate that building rapport through face-to-face interviews may 
be a better approach than self-administered questionnaires and that 
community-based populations or healthcare professionals such as 
nurses represent a good alternative study population.
Study limitations
Bias may have been introduced in our study through self-selection of 
participants with NCDs leading to overestimation of the prevalence 
of NCDs and risk factors. However, we think this is unlikely. We 
limited the impact of absenteeism from work on our study by 
arranging repeat visits to schools; however, if teachers with NCDs 
were more likely not to respond, our results may have resulted in an 
underestimation of the true prevalence of NCDs. Considering that 
NCDs are often asymptomatic until complications set in, it is unlikely 
that knowledge of pre-existing conditions among participants would 
have had a substantial impact on their participation.
A further limitation of our study is that the WHO/ISH risk prediction 
charts that we employed are designed for use in clinical practice to detect 
people aged ≥40 years at high risk for CVD who qualify for treatment. 
The Framingham risk score was purely used to assess the impact of BMI 
on CVD risk, even though it has not been validated in SA. Our study 
population had high rates of overweight and obesity and was relatively 
young, with almost one-fifth aged <40 years. In younger populations, 
it is preferable to determine lifetime risk or to report the relative risk 
compared with people with ideal risk factor levels. Currently there 
are no risk prediction calculators that incorporate BMI to predict risk 
over periods >10 years that have been validated in African countries, 
underscoring the importance of establishing large cohort studies to 
collect the data required to develop these.
Conclusion
Chronic NCDs, in particular CVD, will impose a great burden on 
the education system in Cape Town and possibly in the rest of SA in 
the future. Establishing a cohort study among teachers to measure 
their exposure to risk factors for NCDs, as well as the incidence of 
these diseases over time, will provide the critical information needed 
to plan prevention strategies. Implementing such a project among 
teachers countrywide will require the support of management 
structures within the education system, direct engagement with 
teachers and significant funding from local and international 
sources.
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Appendix 1. Data collection and measurements
A core baseline questionnaire was developed in collaboration with investigators from HSPH and all African sites using the WHO STEPS 
instrument for surveillance of NCD risk factors as a template (http://www.who.int/chp/steps/instrument/en/index.html). The questionnaire 
retrospectively obtained information on demographic and lifestyle factors such as date of birth, gender, ethnicity, educational level, 
socioeconomic factors, tobacco use, alcohol consumption, personal and family members’ medical history related to CVD and risk factors, 
physical activity, self-reported weight and height, and indicators of mental health.
Clinical measurements included height, weight, waist and hip circumference, blood pressure and pulse rate. Measurements were carried 
out by qualified nurses who underwent training, to standardise all measurements at each site. Blood pressure and pulse rate were measured 
according to the SA Hypertension Guidelines using an Omron 705CP-II automatic blood pressure monitor (Omron Healthcare Co., Japan) 
with appropriate cuff sizes (medium for an arm circumference of 22 - 32 cm and large for an arm circumference of 33 - 42 cm). Two 
readings were taken 1 minute apart after a 5-minute rest period, sitting with the participant’s back supported, feet resting on the floor, legs 
uncrossed and arm supported at heart level. If the first two readings differed by >5 mmHg, a third reading was taken. The average of the 
first and second or second and third reading (when done) was taken as the blood pressure. Participants with severe hypertension (≥180 
mmHg/110 mmHg) were referred to their regular doctor. Weight was determined using a Seca 813 digital floor scale (Seca GmbH & Co, 
Germany), calibrated using a weight of known mass. Weight measurements were recorded to the nearest 0.1 kg and taken with subjects 
wearing minimum clothing and no shoes. Height was recorded in centimetres to one decimal using a Seca 213 stadiometer (Seca GmbH 
& Co, Germany) which was placed on a hard, flat, uncarpeted surface. Readings were taken after removing any hair ornamentation and 
shoes, after inhalation and with the reader’s eye at the level of the head piece. BMI was calculated as weight per square metre (kg/m2). 
Waist circumference was measured using a Seca 201 non-elastic measuring tape (Seca GmbH & Co, Germany) placed against the skin at a 
horizontal plane around the midpoint between the lowest rib and the iliac crest and read at the end of normal expiration, and was recorded 
to the nearest 0.1 cm. All anthropometric measurements were performed in duplicate and the average measurement used for analysis.
Random blood samples were collected to determine serum glucose, TC, HDL-C and serum creatinine. A spot urine sample was collected 
to determine the protein/creatinine ratio. Physical measurements and biological samples were not collected from pregnant teachers 
and blood glucose samples were not collected from participants who were on treatment for diabetes mellitus. Biological samples were 
transported daily in an icebox for processing at the Metropolis private pathology laboratory in Cape Town.
Plasma glucose was measured using an enzymatic hexokinase method. TC was determined using an enzymatic colorimetric method 
and HDL-C was measured directly using a homogeneous enzymatic colorimetric test. Serum and urine creatinine was determined using a 
kinetic colorimetric assay that is based on the Jaffé method. Urinary protein was measured using a turbidimetric method. Chemistry tests 
were performed on the Cobas c 501 system (Roche/Hitachi, USA). The GFR was estimated (eGFR) using the re-expressed four-variable 
MDRD study equation: eGFR (mL/min/1.73 m2) = 175 × ((standardised serum creatinine × 0.0113) – 1.154) × (age – 0.203) × F, where 
F = 1 if male and F = 0.742 if female.
